94 related articles for article (PubMed ID: 6128543)
1. N-acetyltransferase phenotypes of bladder cancer patients in a low-risk population.
Mommsen S; Sell A; Barfod N
Lancet; 1982 Nov; 2(8309):1228. PubMed ID: 6128543
[No Abstract] [Full Text] [Related]
2. N-Acetyltransferase phenotype of patients with bladder cancer.
Karakaya AE; Cok I; Sardas S; Gögüs O; Sardas OS
Hum Toxicol; 1986 Sep; 5(5):333-5. PubMed ID: 3770769
[TBL] [Abstract][Full Text] [Related]
3. Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population.
Hanssen HP; Agarwal DP; Goedde HW; Bucher H; Huland H; Brachmann W; Ovenbeck R
Eur Urol; 1985; 11(4):263-6. PubMed ID: 4043164
[TBL] [Abstract][Full Text] [Related]
4. Role of N-acetyltransferase phenotype in human susceptibility to bladder carcinogenic arylamines.
Wolf H; Lower GM; Bryan GT
Scand J Urol Nephrol; 1980; 14(2):161-5. PubMed ID: 7209420
[TBL] [Abstract][Full Text] [Related]
5. N-acetyltransferase phenotype and risk in urinary bladder cancer: approaches in molecular epidemiology. Preliminary results in Sweden and Denmark.
Lower GM; Nilsson T; Nelson CE; Wolf H; Gamsky TE; Bryan GT
Environ Health Perspect; 1979 Apr; 29():71-9. PubMed ID: 510245
[TBL] [Abstract][Full Text] [Related]
6. [Significance of N-acetyltransferase phenotype in development of bladder neoplasms].
Wolf H; Lower GM; Bryan GT
Ugeskr Laeger; 1980 Feb; 142(6):382-5. PubMed ID: 7368384
[No Abstract] [Full Text] [Related]
7. Correlation of the genotypes for N-acetyltransferases 1 and 2 with double bladder and prostate cancers in a case-comparison study.
Wang CY; Jones RF; Debiec-Rychter M; Soos G; Haas GP
Anticancer Res; 2002; 22(6B):3529-35. PubMed ID: 12552951
[TBL] [Abstract][Full Text] [Related]
8. N-acetyltransferase 2 phenotype but not NAT1*10 genotype affects aminobiphenyl-hemoglobin adduct levels.
Probst-Hensch NM; Bell DA; Watson MA; Skipper PL; Tannenbaum SR; Chan KK; Ross RK; Yu MC
Cancer Epidemiol Biomarkers Prev; 2000 Jun; 9(6):619-23. PubMed ID: 10868698
[TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphism and cancer susceptibility: evidence concerning acetyltransferases and cancer of the urinary bladder.
Hein DW
Bioessays; 1988 Dec; 9(6):200-4. PubMed ID: 3072000
[No Abstract] [Full Text] [Related]
10. Association of NAT1 and NAT2 polymorphisms to urinary bladder cancer: significantly reduced risk in subjects with NAT1*10.
Cascorbi I; Roots I; Brockmöller J
Cancer Res; 2001 Jul; 61(13):5051-6. PubMed ID: 11431340
[TBL] [Abstract][Full Text] [Related]
11. Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer.
Cartwright RA; Glashan RW; Rogers HJ; Ahmad RA; Barham-Hall D; Higgins E; Kahn MA
Lancet; 1982 Oct; 2(8303):842-5. PubMed ID: 6126711
[TBL] [Abstract][Full Text] [Related]
12. The biochemical indices of genetic susceptibility to cancer. Acetylation phenotype and bladder cancer.
Hanke J; Krajewska B
Pol J Occup Med; 1988; 1(4):306-11. PubMed ID: 2979565
[No Abstract] [Full Text] [Related]
13. N-Acetyltransferase phenotypes in the urinary bladder carcinogenesis of a low-risk population.
Mommsen S; Barfod NM; Aagaard J
Carcinogenesis; 1985 Feb; 6(2):199-201. PubMed ID: 3971485
[TBL] [Abstract][Full Text] [Related]
14. Genetic association with bladder cancer.
Wolf H
Br Med J; 1979 Nov; 2(6201):1366. PubMed ID: 519454
[No Abstract] [Full Text] [Related]
15. Susceptibility in urinary bladder cancer: acetyltransferase phenotypes and related risk factors.
Mommsen S; Aagaard J
Cancer Lett; 1986 Aug; 32(2):199-205. PubMed ID: 3756846
[TBL] [Abstract][Full Text] [Related]
16. Genetic regulation of N-acetyltransferase in target organs of arylamine tumors: homologous expression in human and hamster bladder and colon.
Hein DW
Proc West Pharmacol Soc; 1991; 34():55-60. PubMed ID: 1788341
[No Abstract] [Full Text] [Related]
17. N-acetyltransferase 2 gene polymorphism as a biomarker for susceptibility to bladder cancer in Bangladeshi population.
Hosen MB; Islam J; Salam MA; Islam MF; Hawlader MZ; Kabir Y
Asia Pac J Clin Oncol; 2015 Mar; 11(1):78-84. PubMed ID: 25376209
[TBL] [Abstract][Full Text] [Related]
18. [Acetylation phenotype in patients with cancer of the bladder. Preliminary report].
Skretowicz J; Polakowski P; Jeromin L; Zasada M; Szymańska J; Krajewska B
Med Pr; 1988; 39(4):241-5. PubMed ID: 3237058
[TBL] [Abstract][Full Text] [Related]
19. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
Wu H; Wang X; Zhang L; Mo N; Lv Z
Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
[TBL] [Abstract][Full Text] [Related]
20. Urinary bladder cancer in a girl with a slow-acetylator genotype and treated with sulphasalazine.
Espin Jaime MT; Moran Penco JM; Garcia Agundez JA; Caballero Loscos MJ; Sanjuan Rodriguez S; Botello Martinez F; Gomez de Tbjada R; Laguna Alvarez E; Benitez Rodriguez I
Br J Urol; 1997 Jul; 80(1):151-2. PubMed ID: 9240200
[No Abstract] [Full Text] [Related]
[Next] [New Search]
